Quidel’s sofia® sars antigen fia updates eua performance data to 96.7% ppa versus pcr; product supports u.s. initiatives to expand access to covid-19 testing in nursing homes; receives ce mark for use with sofia® and sofia® 2 instruments

Quidel corporation (nasdaq: qdel) (“quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnosti

CAH Ratings Summary

CAH Quant Ranking